When John Kanzius, a retired radio and television broadcaster and engineer, was working with a radio frequency generating device aimed at eradicating cancer cells, he could have not imagined that the experiments would eventually cause a salt water solution to release hydrogen, which could then be burned producing very high temperatures, thus becoming a possible substitute for fuel.
This amazing invention works by using a generator that emits 14-megahertz radio waves that bombard a solution of salt and water. No one knows for certain what happens thereafter but everything indicates that the sodium chloride may weaken the bonds between the strong oxygen and hydrogen atoms in water and the radio waves break apart the bonds and liberate flammable hydrogen gas molecules.
A simple spark is all is needed then to ignite the hydrogen, generating an intense flame that produces enough heat to power up an engine.
Kanzius never meant to invent a substitute for fuel and he is not pursuing that goal neither. Diagnosed with leukemia in 2002, he began building his radio-wave blaster to research the subject of cancer treatment by his own experiences undergoing chemotherapy.
To kill cancer cells using Kanzius RF Therapy, cancer cells are first tagged with tiny objects known as nanoparticles, such as SWNTs and GNPs. When the RF (radio frequency) transmitter apparatus exposes the nanoparticles to the radio frequency signal they heat up, destroying the cancer cells, but don’t damage healthy cells nearby.
As of 2007–04-23, preliminary research using the Kanzius RF device at the M. D. Anderson Cancer Center in Houston (by Dr. Steven A. Curley, Professor in Surgical Oncology) and The University of Pittsburgh Medical Center (by Dr. David A. Geller, co-director of the Liver Cancer Center) has shown promising results. As of 1st November 2007, preliminary trials with rabbits have turned up a 100% success rate, with the tumors successfully eliminated and the rabbits remaining unharmed. If federal approval is granted, testing on human patients would be the next step.
Steven A. Curley, who pioneered the clinical studies that led to FDA approval of radiofrequency ablation to treat unresectable primary and metastatic hepatobiliary malignancies, referred to the method as “one of the most exciting developments in years.”
The prototype of the device was built by Kanzius himself in his home.
See the video below:
The Kanzius RF Machine uses a capacitor to focus radio waves in a transmitting head to send them to a receiving head. Between the two machines there is a space where the cancerous part is placed so the radio waves can be sent through it.
Four units are currently in service at the MD Anderson Cancer Center and the University of Pittsburgh Medical Center. The University of Pittsburgh Medical Center received their first unit in May of 2005, and MD Anderson Cancer Center received their first machine in January of 2006. John Kanzius’ predicts a near term demand of 3,000 to 5,000 units with long term expectations at 50,000 to 100,000 units.
Until targeting is fully viable, Kanzius is considering only making the machine available only to a few well renowned medical centers. As patent holder, he decides who is able to purchase the machines.